PDL BioPharma, Inc.
The momentum for this stock is not very good. PDL BioPharma, Inc. is not a good value stock. PDL BioPharma, Inc. is not a good growth stock. PDL BioPharma, Inc. is not very popular among insiders. PDL BioPharma, Inc. is a mediocre stock to choose.
Log in to see more information.
PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the followi...
News
BiomX Announces the Appointment of Susan Blum to its Board of Directors
Globe Newswire CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) ( BiomX or the Company ), a clinical-stage company advancing novel natural and...\n more…